Quinolone and Macrolide Resistance in Campylobacter jejuni and C. coli: Resistance Mechanisms and Trends in Human Isolates

Abstract

The incidence of human Campylobacter jejuni and C. coli infections has increased markedly in many parts of the world in the last decade as has the number of quinolone-resistant and, to a lesser extent, macrolide-resistant Campylobacter strains causing infections. We review macrolide and quinolone resistance in Campylobacter and track resistance trends in human clinical isolates in relation to use of these agents in food animals. Susceptibility data suggest that erythromycin and other macrolides should remain the drugs of choice in most regions, with systematic surveillance and control measures maintained, but fluoroquinolones may now be of limited use in the empiric treatment of Campylobacter infections in many regions.

References 63

1. 1.

   Aarestrup F. M., Nielsen E. M., Madsen M., Engberg J. Antimicrobial susceptibility patterns of thermophilic Campylobacter spp. from humans, pigs, cattle, and broilers in Denmark. Antimicrob Agents Chemother. 1997;41(10):2244-2250.

   Not in our library10.1128/aac.41.10.2244

2. 2.

   Adler-Mosca H., Lüthy-Hottenstein J., Martinetti Lucchini G., Burnens A., Altwegg M. Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin. Eur J Clin Microbiol Infect Dis. 1991;10(11):953-957.

   Not in our library10.1007/bf02005451

3. 3.

   Allos B. M., Blaser M. J. Campylobacter jejuni and the expanding spectrum of related infections. Clin Infect Dis. 1995;20(5):1092-1101.

   Not in our library10.1093/clinids/20.5.1092

4. 4.

   Baker C. N. The E-Test and Campylobacter jejuni. Diagn Microbiol Infect Dis. 1992;15(5):469-472.

   Not in our library10.1016/0732-8893(92)90092-8

5. 5.

   Berghold Christian, Fürpaß Therasia, Marth Egon. Further increase in ciprofloxacin-resistant Campylobacter jejuni/coli in Styria, Austria. Clin Microbiol Infect. 1999;5(1):59-60.

   Not in our library10.1111/j.1469-0691.1999.tb00102.x

6. 6.

   Bowler I. C., Connor M., Lessing M. P., Day D. Quinolone resistance and Campylobacter species. J Antimicrob Chemother. 1996;38(2):315-315.

   Not in our library10.1093/jac/38.2.315

7. 7.

   Cabrita J., Rodrigues J., Bragança F., Morgado C., Pires I., Gonçalves A. P. Prevalence, biotypes, plasmid profile and antimicrobial resistance of Campylobacter isolated from wild and domestic animals from northeast Portugal. J Appl Bacteriol. 1992;73(4):279-285.

   Not in our library10.1111/j.1365-2672.1992.tb04978.x

8. 8.

   Charvalos E., Tselentis Y., Hamzehpour M. M., Köhler T., Pechere J. C. Evidence for an efflux pump in multidrug-resistant Campylobacter jejuni. Antimicrob Agents Chemother. 1995;39(9):2019-2022.

   Not in our library10.1128/aac.39.9.2019

9. 9.

   Chatzipanagiotou S., Papavasiliou E., Malamou-Lada E. Isolation of Campylobacter jejuni strains resistant to nalidixic acid and fluoroquinolones from children with diarrhea in Athens, Greece. Eur J Clin Microbiol Infect Dis. 1993;12(7):566-568.

   Not in our library10.1007/bf01970969

10. 10.

    Dowling J., MacCulloch D., Morris A. J. Antimicrobial susceptibility of Campylobacter and Yersinia enterocolitica isolates. N Z Med J. 1998;111(1070):281-281.

    Not in our library

11. 11.

    Dryden M. S., Gabb R. J., Wright S. K. Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. Clin Infect Dis. 1996;22(6):1019-1025.

    Not in our library10.1093/clinids/22.6.1019

12. 12.

    Ellis-Pegler R. B., Hyman L. K., Ingram R. J., McCarthy M. A placebo controlled evaluation of lomefloxacin in the treatment of bacterial diarrhoea in the community. J Antimicrob Chemother. 1995;36(1):259-263.

    Not in our library10.1093/jac/36.1.259

13. 13.

    Endtz H. P., Mouton R. P., van der Reyden T., Ruijs G. J., Biever M., van Klingeren B. Fluoroquinolone resistance in Campylobacter spp isolated from human stools and poultry products. Lancet. 1990;335(8692):787-787.

    Not in our library10.1016/0140-6736(90)90897-e

14. 14.

    Endtz H. P., Ruijs G. J., van Klingeren B., Jansen W. H., van der Reyden T., Mouton R. P. Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicrob Chemother. 1991;27(2):199-208.

    Not in our library10.1093/jac/27.2.199

15. 15.

    Engberg Jørgen, Andersen Sigrid, Skov Robert, Aarestrup Frank Møller, Gerner-Smidt Peter. Comparison of two agar dilution methods and three agar diffusion methods, including the Etest, for antibiotic susceptibility testing of thermophilic Campylobacter species. Clin Microbiol Infect. 1999;5(9):580-584.

    Not in our library10.1111/j.1469-0691.1999.tb00440.x

16. 16.

    Engberg Jørgen, Gerner-Smidt Peter, Scheutz Flemming, Møller Nielsen Eva, On Stephen Louis William, Mølbak Kåre. Water-borne Campylobacter jejuni infection in a Danish town---a 6-week continuous source outbreak. Clin Microbiol Infect. 1998;4(11):648-656.

    Not in our library10.1111/j.1469-0691.1998.tb00348.x

17. 17.

    Feierl G., Pschaid A., Sixl B., Marth E. Increase of ciprofloxacin resistance in Campylobacter species in Styria, Austria. Zentralbl Bakteriol. 1994;281(4):471-474.

    Not in our library10.1016/s0934-8840(11)80333-6

18. 18.

    Funke G., Baumann R., Penner J. L., Altwegg M. Development of resistance to macrolide antibiotics in an AIDS patient treated with clarithromycin for Campylobacter jejuni diarrhea. Eur J Clin Microbiol Infect Dis. 1994;13(7):612-615.

    Not in our library10.1007/bf01971317

19. 19.

    Gallardo F., Gascón J., Ruiz J., Corachan M., Jimenez de Anta M., Vila J. Campylobacter jejuni as a cause of traveler's diarrhea: clinical features and antimicrobial susceptibility. J Travel Med. 1998;5(1):23-26.

    Not in our library10.1111/j.1708-8305.1998.tb00451.x

20. 20.

    Gaudreau C., Gilbert H. Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada. Antimicrob Agents Chemother. 1998;42(8):2106-2108.

    Not in our library10.1128/aac.42.8.2106

21. 21.

    Gibreel A., Sjögren E., Kaijser B., Wretlind B., Sköld O. Rapid emergence of high-level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyrA and parC. Antimicrob Agents Chemother. 1998;42(12):3276-3278.

    Not in our library10.1128/aac.42.12.3276

22. 22.

    Gootz T. D., Martin B. A. Characterization of high-level quinolone resistance in Campylobacter jejuni. Antimicrob Agents Chemother. 1991;35(5):840-845.

    Not in our library10.1128/aac.35.5.840

23. 23.

    Hirschl A. M., Wolf D., Berger J., Rotter M. L. In vitro susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Austria to erythromycin and ciprofloxacin. Zentralbl Bakteriol. 1990;272(4):443-447.

    Not in our library10.1016/s0934-8840(11)80045-9

24. 24.

    Hoge C. W., Gambel J. M., Srijan A., Pitarangsi C., Echeverria P. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis. 1998;26(2):341-345.

    Not in our library10.1086/516303

25. 25.

    Hänninen M. L., Pajarre S., Klossner M. L., Rautelin H. Typing of human Campylobacter jejuni isolates in Finland by pulsed-field gel electrophoresis. J Clin Microbiol. 1998;36(6):1787-1789.

    Not in our library10.1128/jcm.36.6.1787-1789.1998

26. 26.

    Kuschner R. A., Trofa A. F., Thomas R. J., Hoge C. W., Pitarangsi C., Amato S., Olafson R. P., Echeverria P., Sadoff J. C., Taylor D. N. Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. Clin Infect Dis. 1995;21(3):536-541.

    Not in our library10.1093/clinids/21.3.536

27. 27.

    Li C. C., Chiu C. H., Wu J. L., Huang Y. C., Lin T. Y. Antimicrobial susceptibilities of Campylobacter jejuni and coli by using E-test in Taiwan. Scand J Infect Dis. 1998;30(1):39-42.

    Not in our library10.1080/003655498750002286

28. 28.

    Lim Y. S., Tay L. A one-year study of enteric Campylobacter infections in Singapore. J Trop Med Hyg. 1992;95(2):119-123.

    Not in our library

29. 29.

    Mattila L., Peltola H., Siitonen A., Kyrönseppä H., Simula I., Kataja M. Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons. Clin Infect Dis. 1993;17(4):779-782.

    Not in our library10.1093/clinids/17.4.779

30. 30.

    Molina J., Casin I., Hausfater P., Giretti E., Welker Y., Decazes J., Garrait V., Lagrange P., Modaï J. Campylobacter infections in HIV-infected patients: clinical and bacteriological features. AIDS. 1995;9(8):881-885.

    Not in our library10.1097/00002030-199508000-00008

31. 31.

    Moore J. E., Madden R. H., Kerr J. R., Wilson T. S., Murphy P. G. Erythromycin-resistant thermophilic Campylobacter species isolated from pigs. Vet Rec. 1996;138(13):306-307.

    Not in our library10.1136/vr.138.13.306

32. 32.

    Murphy G. S., Echeverria P., Jackson L. R., Arness M. K., LeBron C., Pitarangsi C. Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994. Clin Infect Dis. 1996;22(5):868-869.

    Not in our library10.1093/clinids/22.5.868

33. 33.

    Mølbak K., Baggesen D. L., Aarestrup F. M., Ebbesen J. M., Engberg J., Frydendahl K., Gerner-Smidt P., Petersen A. M., Wegener H. C. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104. N Engl J Med. 1999;341(19):1420-1425.

    Not in our library10.1056/nejm199911043411902

34. 34.

    Navarro F., Miró E., Mirelis B., Prats G. Campylobacter spp antibiotic susceptibility. J Antimicrob Chemother. 1993;32(6):906-907.

    Not in our library10.1093/jac/32.6.906

35. 35.

    Nielsen E. M., Engberg J., Madsen M. Distribution of serotypes of Campylobacter jejuni and C. coli from Danish patients, poultry, cattle and swine. FEMS Immunol Med Microbiol. 1997;19(1):47-56.

    Not in our library10.1111/j.1574-695x.1997.tb01071.x

36. 36.

    Nielsen E. M., Nielsen N. L. Serotypes and typability of Campylobacter jejuni and Campylobacter coli isolated from poultry products. Int J Food Microbiol. 1999;46(3):199-205.

    Not in our library10.1016/s0168-1605(98)00194-9

37. 37.

    On S. L., Nielsen E. M., Engberg J., Madsen M. Validity of SmaI-defined genotypes of Campylobacter jejuni examined by SalI, KpnI, and BamHI polymorphisms: evidence of identical clones infecting humans, poultry, and cattle. Epidemiol Infect. 1998;120(3):231-237.

    Not in our library10.1017/s0950268898008668

38. 38.

    Orr K. E., Lightfoot N. F., Sisson P. R., Harkis B. A., Tweddle J. L., Boyd P., Carroll A., Jackson C. J., Wareing D. R., Freeman R. Direct milk excretion of Campylobacter jejuni in a dairy cow causing cases of human enteritis. Epidemiol Infect. 1995;114(1):15-24.

    Not in our library10.1017/s0950268800051876

39. 39.

    Owen R. J., Leeton S. Restriction fragment length polymorphism analysis of the flaA gene of Campylobacter jejuni for subtyping human, animal and poultry isolates. FEMS Microbiol Lett. 1999;176(2):345-350.

    Not in our library10.1111/j.1574-6968.1999.tb13682.x

40. 40.

    Pearson A. D., Greenwood M. H., Donaldson J., Healing T. D., Jones D. M., Shahamat M., Feltham R. K., Colwell R. R. Continuous source outbreak of campylobacteriosis traced to chicken. J Food Prot. 2000;63(3):309-314.

    Not in our library10.4315/0362-028x-63.3.309

Cited by papers we hold 14

• Antibiotic Resistance in Bacteria—A Review · 2022
  No notice
• The gut microbiome: an under-recognised contributor to the COVID-19 pandemic? · 2020
  Not checked
• Validation of the T86I mutation in the gyrA gene as a highly reliable real time PCR target to detect Fluoroquinolone-resistant Campylobacter jejuni · 2020
  Not checked
• Isothiocyanates: An Overview of Their Antimicrobial Activity against Human Infections · 2018
  No notice
• Trends in fluoroquinolone resistance in Campylobacter · 2018
  No notice
• Reducing antimicrobial use in food animals · 2017
  No notice
• The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin · 2017
  No notice
• Antibiotic resistance profile and RAPD analysis of Campylobacter jejuni isolated from vegetables farms and retail markets · 2016
  Not checked
• Antibiotics in agriculture and the risk to human health: how worried should we be? · 2014
  No notice
• Foodborne Campylobacter: Infections, Metabolism, Pathogenesis and Reservoirs · 2013
  No notice
• Antimicrobial Resistance Mechanisms among Campylobacter · 2013
  No notice
• Antimicrobial Resistance among Campylobacter Strains, United States, 1997–2001 · 2004
  No notice
• Increasing Fluoroquinolone Resistance in Campylobacter jejuni, Pennsylvania, USA,1982–20011 · 2002
  Not checked
• Human Campylobacteriosis in Developing Countries1 · 2002
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.